 Lung Diseases, Interstitial
"Lung Diseases, Interstitial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Descriptor ID |
D017563
|
| MeSH Number(s) |
C08.381.483
|
| Concept/Terms |
Lung Diseases, Interstitial- Lung Diseases, Interstitial
- Interstitial Lung Disease
- Lung Disease, Interstitial
- Interstitial Lung Diseases
- Diffuse Parenchymal Lung Diseases
Pneumonia, Interstitial- Pneumonia, Interstitial
- Interstitial Pneumonia
- Interstitial Pneumonias
- Pneumonias, Interstitial
- Pneumonitis, Interstitial
- Interstitial Pneumonitides
- Interstitial Pneumonitis
- Pneumonitides, Interstitial
|
Below are MeSH descriptors whose meaning is more general than "Lung Diseases, Interstitial".
Below are MeSH descriptors whose meaning is more specific than "Lung Diseases, Interstitial".
This graph shows the total number of publications written about "Lung Diseases, Interstitial" by people in this website by year, and whether "Lung Diseases, Interstitial" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 | | 1997 | 1 | 0 | 1 | | 1998 | 1 | 2 | 3 | | 1999 | 1 | 1 | 2 | | 2000 | 1 | 0 | 1 | | 2001 | 1 | 0 | 1 | | 2002 | 5 | 0 | 5 | | 2003 | 3 | 1 | 4 | | 2004 | 4 | 2 | 6 | | 2005 | 6 | 2 | 8 | | 2006 | 8 | 2 | 10 | | 2007 | 8 | 0 | 8 | | 2008 | 5 | 0 | 5 | | 2009 | 12 | 1 | 13 | | 2010 | 8 | 1 | 9 | | 2011 | 6 | 1 | 7 | | 2012 | 12 | 2 | 14 | | 2013 | 18 | 0 | 18 | | 2014 | 12 | 1 | 13 | | 2015 | 11 | 3 | 14 | | 2016 | 14 | 2 | 16 | | 2017 | 19 | 1 | 20 | | 2018 | 13 | 0 | 13 | | 2019 | 25 | 1 | 26 | | 2020 | 18 | 2 | 20 | | 2021 | 21 | 2 | 23 | | 2022 | 30 | 1 | 31 | | 2023 | 34 | 0 | 34 | | 2024 | 31 | 3 | 34 | | 2025 | 25 | 2 | 27 | | 2026 | 3 | 1 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Lung Diseases, Interstitial" by people in Profiles.
-
Dulcich G, Mestas Nuñez M, Bang TJ, Zuccarino F, Perez-Johnston R, Cool C, Vargas D. Imaging Findings of Smoking-related Pulmonary Parenchymal Disease. Radiographics. 2026 Jun; 46(6):e250167.
-
Oh AS, Humphries SM, Chung A, Weigt SS, Brown M, Kim GHJ, Lee D, Belperio JA, Goldin JG. Quantitative CT and Artificial Intelligence in Chronic Lung Disease. J Thorac Imaging. 2026 Mar 01; 41(2).
-
Hwang J, Cerro Chiang G, Huie TJ, Kreider ME, Zaman T. Advancing practitioner knowledge in interstitial lung disease: a review of free, online resources. ATS Sch. 2026 Mar 01; 7(1):74-85.
-
Perelas A, Winter DL, Swigris JJ, Strek ME, Highland KB. Interstitial pneumonia with autoimmune features: A literature review. Respir Med. 2026 02; 252:108641.
-
Humphries SM, Chung A, Swigris JJ, Oh AS, Walsh SLF, Lynch DA, Goldin JG, Kim GHJ. Quantification of Interstitial Lung Diseases, From the AJR Special Series on Quantitative Imaging. AJR Am J Roentgenol. 2025 Dec; 225(6):e2432053.
-
Ormsby AL, Matson SM, Griffith MR, Demoruelle MK, Lee JS. Subclinical Interstitial Lung Disease in Rheumatoid Arthritis: Implications for Early Detection and Management. Chest. 2026 Apr; 169(4):1018-1025.
-
El Husseini K, Lee JS, Juge PA, Ebstein E, Ottaviani S, Borie R, Bancal C, Debray MP, Kannengiesser C, Ba I, Marchand-Adam S, Richez C, Nunes H, Avouac J, Flipo RM, Wemeau L, Boissier MC, Schaeverbeke T, Saidenberg Kermanac'h N, Kawano-Dourado L, Cottin V, Wolters PJ, Granger B, Dieudé P, Crestani B. Short telomere length is associated with accelerated lung disease progression in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J. 2025 Dec; 66(6).
-
Bae SS, Markovic D, Saygin D, Sullivan D, Yamaguchi K, Moghadam-Kia S, Oddis CV, Abtin F, Kim GHJ, Marder G, Venuturupalli S, Dellaripa PF, Danoff S, Doyle T, Hunninghake G, Lee JS, Falk J, Johnson C, Goldin J, Tashkin D, Charles-Schoeman C, Aggarwal R. Associations between 6-minute walk distance and physiologic measures and clinical outcomes in myositis-associated interstitial lung disease. Rheumatology (Oxford). 2025 Dec 01; 64(SI):SI79-SI87.
-
Harris KJR, Ludtke EA, Goldberg B, McCall NN, Hewlett JC, Wilfong EM. Tacrolimus as first-line therapy in a US cohort of idiopathic inflammatory myopathies related interstitial lung disease. Rheumatology (Oxford). 2025 Dec 01; 64(SI):SI179-SI183.
-
Aggarwal R, Pongtarakulpanit N, Sullivan DI, Moghadam-Kia S, Bae SS, Wilkerson J, Saygin D, Marder G, Venuturupalli S, Dellaripa PF, Danoff SK, Doyle T, Hunninghake GM, Lee JS, Fischer A, Falk J, Johnson C, Koontz D, Ascherman DP, Oddis CV. Abatacept for the treatment of myositis-associated interstitial lung disease. Rheumatology (Oxford). 2025 Dec 01; 64(SI):SI156-SI168.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|